- Home
- TRN vs KNSA Comparison
TRN vs KNSA Comparison
Compare TRN & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRN
- KNSA
- Stock Information
- Founded
- TRN 1933
- KNSA 2015
- Country
- TRN United States
- KNSA United Kingdom
- Employees
- TRN N/A
- KNSA N/A
- Industry
- TRN Railroads
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- TRN Industrials
- KNSA Health Care
- Exchange
- TRN Nasdaq
- KNSA Nasdaq
- Market Cap
- TRN 2.2B
- KNSA 2.6B
- IPO Year
- TRN N/A
- KNSA 2018
- Fundamental
- Price
- TRN $27.97
- KNSA $39.05
- Analyst Decision
- TRN Hold
- KNSA Strong Buy
- Analyst Count
- TRN 1
- KNSA 7
- Target Price
- TRN $24.00
- KNSA $44.00
- AVG Volume (30 Days)
- TRN 490.5K
- KNSA 392.4K
- Earning Date
- TRN 10-30-2025
- KNSA 10-28-2025
- Dividend Yield
- TRN 4.29%
- KNSA N/A
- EPS Growth
- TRN N/A
- KNSA N/A
- EPS
- TRN 1.14
- KNSA 0.07
- Revenue
- TRN $2,519,800,000.00
- KNSA $529,332,000.00
- Revenue This Year
- TRN N/A
- KNSA $37.21
- Revenue Next Year
- TRN $7.24
- KNSA $12.07
- P/E Ratio
- TRN $24.53
- KNSA $582.26
- Revenue Growth
- TRN N/A
- KNSA 56.18
- 52 Week Low
- TRN $22.38
- KNSA $17.82
- 52 Week High
- TRN $39.83
- KNSA $39.12
- Technical
- Relative Strength Index (RSI)
- TRN 50.03
- KNSA 68.90
- Support Level
- TRN $27.44
- KNSA $37.61
- Resistance Level
- TRN $28.40
- KNSA $38.83
- Average True Range (ATR)
- TRN 0.52
- KNSA 1.05
- MACD
- TRN -0.03
- KNSA 0.03
- Stochastic Oscillator
- TRN 38.15
- KNSA 96.69
About TRN Trinity Industries Inc.
Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.